Why AbbVie Stock Cruised to an Almost 6% Gain Today @themotleyfool #stocks $ABBV $^GSPC

Why AbbVie Stock Cruised to an Almost 6% Gain Today @themotleyfool #stocks $ABBV $^GSPC

Key PointsIt's about to significantly expand its biologics research and manufacturing effort at a facility in Massachusetts.This should cost it a cool $70 million.10 stocks we like better than AbbVie › The announcement of a new buildout, as well as developments on the political front, were the factors driving up AbbVie (NYSE: ABBV) stock on Wednesday. The pharmaceutical company's shares rose by nearly 6% in value as a result, during a session wh…